4-(n-maleimido)benzyltrimethylammonium has been researched along with ethyl methanesulfonate in 1 studies
| Studies (4-(n-maleimido)benzyltrimethylammonium) | Trials (4-(n-maleimido)benzyltrimethylammonium) | Recent Studies (post-2010) (4-(n-maleimido)benzyltrimethylammonium) | Studies (ethyl methanesulfonate) | Trials (ethyl methanesulfonate) | Recent Studies (post-2010) (ethyl methanesulfonate) |
|---|---|---|---|---|---|
| 19 | 0 | 2 | 2,017 | 4 | 307 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, JB; Sullivan, DA | 1 |
1 other study(ies) available for 4-(n-maleimido)benzyltrimethylammonium and ethyl methanesulfonate
| Article | Year |
|---|---|
Mapping the agonist binding site of the nicotinic acetylcholine receptor. Orientation requirements for activation by covalent agonist.
Topics: Acetylcholine; Affinity Labels; Alkylation; Animals; Binding Sites; Cysteine; Dose-Response Relationship, Drug; Ethyl Methanesulfonate; Indicators and Reagents; Kinetics; Mesylates; Models, Chemical; Mutagenesis; Nicotinic Agonists; Patch-Clamp Techniques; Protein Structure, Quaternary; Quaternary Ammonium Compounds; Receptors, Nicotinic; Time Factors; Transcription, Genetic; Xenopus | 2000 |